Instructions for Authors

The journal “Journal of Pre-Clinical and Clinical Research” using the Open Access* model publishes: original and review articles, letters to the editors, and other materials. All original articles, review articles and case reports are reviewed. The journal will consider articles from every legitimate specialty. We are particularly interested in: medicine, human and animal physiology, clinical pharmacology, oncology, molecular cell biology, toxicology, biotechnology, biophysics.

* „Journal of Pre-Clinical and Clinical Research” is an open access journal, which means that the journal offers free and immediate access to its contents to promote the unrestricted global exchange of knowledge. The free availability means that any users are permitted to "read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from gaining access to the internet itself. The only constraint on reproduction and distribution, and the only role for copyright in this domain, should be to give authors control over the integrity of their work and the right to be properly acknowledged and cited" (Budapest Open Access Initiative, https://www.budapestopenaccessinitiative.org/read).

JPCCR endorses ORCID ( https://orcid.org/about/what-is-orcid/mission) and requires that all authors provide an ORCID iD when submitting a manuscript. We encourage coauthors to register and use their ORCID as well.

1. Original articles, short reports, review articles and case reports should be submitted to the Editors exclusively by electronic panel. Please use the editorial panel available on the website: www.jpccr.eu passing to the bookmark "Submit your paper", and follow further instructions.

2. Original articles must contain the following: introduction, objectives, material and methods, results, discussion, conclusions, and references. Abstracts of original articles should consist of 1,400-1,800 characters, including spaces, and divided into: introduction and objective, materials and methods, results, conclusions. Original articles should not exceed 20,000 characters including spaces, but excluding abstract and references; maximum 25 references. The number of Tables and Figures should not exceed 8.

3. Review articles must contain: introduction and objective, review methods (precisely described criteria of selection and exclusion of source publications indicating their limitations and/or qualities, providing the methods of literature search – electronic databases, review of journals), description of the state of knowledge, summary, and references. Abstracts of review articles should consist of 1400-1800 characters, including spaces, and divided into: introduction and objective, review methods, brief description of the state of knowledge, summary. Review articles should not exceed 30,000 characters including spaces, but excluding abstract and references; maximum 50 references. It is advisable to include most important data in tables and figures – the information contained there should not be repeated in the text. The number of Tables and Figures should not exceed 8.

4. Original and review articles must contain 3 - 6 key words selected with consideration of the terms contained in ‘Medical Subject Headings’ MeSH.

5. Ethical consideration
Studies involving experimental animals and humans must be carried out according to the guiding principles of the Declaration of Helsinki. Studies must have been approved by the Institutional Ethical Committee on Human Research at the authors’ institution, and subjects must have given informed consent for participation in the study. All patient personal data must be kept confidential, and all images should be anonymized. Information regarding the ethical committee approval for conducting the research and the informed consent of patients for participating in the studies should be included in the methods section of those articles, in which the diagnostic intervention or the treatment result from non-routine procedures.

6. List of references:
The list of references is the responsibility of the author. References should be quoted in square brackets in order of citation. References must be in accordance with the principles established by the ‘Uniform Requirements for Manuscripts Submitted to Biomedical Journals’

The list of references must be sent directly in the editorial system.

Authors should focus on recent papers and papers older than eight years should not be included except for an overriding purpose (min. 75%)

Each reference should contain: surnames and first letters of authors’ names, title of the article, abbreviated title of the journal, year of publication, volume number, issue number, numbers of the first and last pages. If there are more than three authors, after the third name, ‘et al.’ should be written.
Abbreviated titles of journals indexed on the Medline (PubMed) database should be quoted according to the NLM Catalogue (http://www.ncbi.nlm.nih.gov/nlmcatalog), and the titles of the remaining journals according to the version provided by the editors of individual journals.
If the article has a DOI (Digital Object Identifier) number, please enter it at the end of the bibliographic record as a full link, e.g. https://doi.org/10.26444/jpccr/93936.
The website references should contain the date of downloading or reviewing of the file in brackets after the URL address (Uniform Resource Locator). Punctuation must be maintained precisely according to the examples of references presented below:

Article in a journal
Nurowska E, Tumiatti V, Dworakowska B. Effect of polyamines on the nicotinic ACh receptor. J Pre Clin Clin Res. 2018;12(3):73-76. https://doi.org/10.26444/jpccr/93936.

Books and monographs
Ballou SP, Kushner I, Kelly W, et al. Laboratory evaluation of inflammation. Textbook of Rheumatology. 5th ed. Philadelphia,1996.

Section in a book
Krotochwil-Skrzypkowa M. Post-vaccination reactions and complications. In: Dębiec B, Magdzik W, editors. Preventive vacinations. Ed. 2. Warsaw; 1991. p. 76-81.

Phillips SJ, Whisnant JP. Hypertension and stroke. In: Laragh JH, Brenner BM, editors. Hypertension: pathophysiology, diagnosis, and management. 2nd ed. New York: Raven Press; 1995. p. 465-78.

Conference material
Kimura J, Shibasaki H, editors. Recent advances in clinical neurophysiology. Proceedings of the l0th International Congress of EMG and Clinical Neurophysiology; 1995 Oct 15-19; Kyoto, Japan. Amsterdam, Elsevier; 1996.

Website materials
Caron J. Predictors of quality of life in schizophrenia. www.scie-socialcareonline.org.uk/profile.asp?guid=bbc52e0e-c00f-4c05-8a42-49c123963900 (access: 2010.04.29).

7. Evaluation of the manuscript (principle of reviewing publications)
-The Editor-in-Chief of JPCCR makes a preliminary assessment from the aspect of compatibility of the article within the scope of problems of JPCCR, and in the absence of such compatibility has the right to reject the article.
- After qualification of the article for further processing, the manuscript will be sent to at least two reviewers.
- When submitting work the author is asked to provide the data (name and address e-mail) of the two suggested reviewers. Editorial Staff reserve the right decision whether to use or not the suggested reviewers in the review process work. Reviewer cannot be co-authored publications, or be affiliated in an author.
- Articles are reviewed anonymously, and subsequently the author(s) will become acquainted with the reviews without the surnames of the persons reviewing the articles being revealed (once a year, the journal publishes the list of cooperating reviewers).
- The surnames of reviewers of individual publications/issues are not revealed; once a year, the journal publishes the list of cooperating reviewers.
- The process of reviewing the manuscript should not last longer than 6 weeks; however, the Editors cannot guarantee a specified date of making the decision.
- The review is in written form (a review form is provided on the website of the journal) and ends with an unequivocal conclusion concerning the acceptance of the manuscript for publication or its rejection.
- Based on the review received, the Editor-in-Chief of JPCCR makes the decision concerning acceptance or rejection of the article for publication in JPCCR.
- In the case when, according to the reviewers’ comments, the manuscript requires correction, the Editor-in-Chief of JPCCR may make the decision, after the necessary corrections have been made by the author(s), about the resubmission of the manuscript for further review.
- The article which has been accepted by the Editor-in-Chief of JPCCR is included in the registration process, and is ascribed a DOI number.
- An article ascribed a DOI number is published on the website of the journal and denoted as an accepted article, which awaits qualification for the specified issue of JPCCR.
- The author(s) of articles accepted for publication are informed by mail concerning the positive decision about publication of the said article.
- The author(s) of articles which have not been accepted for publication are informed of this fact by mail.

8. An explanation concerning “ ghostwriting” and “ guest authorship”
– The editors require from the authors of articles that they reveal the contribution of individual authors to the manuscript (quoting their affiliation and contribution, i.e. who is the author of the concept, assumptions, methods, protocol, etc., used while writing the manuscript), the primary author bearing the responsibility for the manuscript submitted.
– The editors explain that “ ghostwriting” (“ ghostwriting” is undertaken by a professional writer who writes books, articles, etc., based on detailed information provided, but the work is officially credited to someone else, without the name of the ghostwriter being mentioned) and “ guest authorship” (occurs when the contribution of the author is very little or not at all, despite which he/she is the named author/co-author of the manuscript) are a manifestation of scientific unreliability, and all detected cases will be disguised, including the informing of proper parties (institutions employing the authors, scientific societies, scientific editors associations, etc.).
– The Editors request provision of information concerning the sources of financing the article, contribution of scientific-research institutions, associations and other parties (‘financial disclosure’).
– The editors document any manifestations of scientific unreliability, especially the breaking and violating of ethical principles in effect in science.
- All manuscripts submitted to the journal will be checked using plagiarism detection software.

9. Reservations
- Articles which do not fall within the scope of problems of the journal and do not satisfy the requirements concerning the text layout and references will not be accepted. The Editors reserve the right to correct syntax errors, correct nomenclature, and make necessary abbreviations, correct and supplement references without prior consultation with the author. The Editors do not verify quotations and translations thereof; therefore, any quotations and their translations from foreign languages must be prepared by the responsible author of the article.
- Changes to authorship. This policy concerns the addition, deletion, or rearrangement of author names in the authorship of accepted manuscripts.
Before the accepted manuscript is published in an online issue: Requests to add or remove an author, or to rearrange the author names, must be sent to the Journal Manager from the corresponding author of the accepted manuscript and must include: (a) the reason the name should be added or removed, or the author names rearranged and (b) written confirmation (email, fax, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed. Requests that are not sent by the corresponding author will be forwarded to the corresponding author, who must follow the procedure as described above. Note that: publication of the accepted manuscript in an online issue is suspended until authorship has been agreed.
After the accepted manuscript is published in an online issue: Any requests to add, delete, or rearrange author names in an article published in an online issue will follow the same policies as noted above and result in a corrigendum.

10. Statements
Submission of an article for publication in the journal Journal of Pre-Clinical and Clinical Research is unequivocal with the provision of a statement by the author that there is no ‘conflict of interests’ which occurs when the author remains in a financial or personal relationships which unjustly affects his/her actions associated with publication of the manuscript.

Prior to the beginning of the publication process the author or authors of submitted articles are obliged to:

a) submission to JPCCR of a written certificate signed by the all authors that the article has not been published anywhere previously, or submitted for publication to any other journal
b) submit to JPCCR a written certificate with the legible signatures of all authors, concerning copyright transfer of the manuscript to the Institute, signed by the author(s) of the article and accept the full text of the Creative Commons Attribution-NonCommercial 3.0 Poland (also known as CC BY-NC);
c) submit to JPCCR a cover letter;

Certificates referred to in Clause ( a) and ( b) may also be provided in an electronic form, as a scan of the document signed by the author(s).
The Certificates should be provided together with the manuscript files.

Dear authors, in the case of a change being made to the title of an article, please provide new certificates with the proposed CHANGED TITLE with the legible signatures of ALL AUTHORS

11. Payment
Prior to the beginning of the publication process the author or authors of submitted articles are obliged to payment of the fee in the amount: 24 EUR (or 100 PLN), to the bank account on the JPCCR website, providing name and surname of the author, and in case of several authors, providing the name and surname of the author indicated for correspondence and the title of the submitted article, with the reservation that as the payment is considered as cash inflow on the bank account indicated on the JPCCR website, this fee is non-refundable

The article which has been accepted by the Editor-in-Chief of JPCCR is included in the registration process after receipt of the publication fee in the amount of 90 EUR (or 400 PLN) to the bank account of the Institute indicated on the JPCCR website, providing the name and surname of the author, and in the case of several authors, providing the name and surname of corresponding author, the title of the submitted article, and the number ascribed to the manuscript, with the reservation that the payment is considered as cash inflow to the bank account indicated on the JPCCR website.

Data for transfer (24 EUR and 90 EUR):
Instytut Medycyny Wsi
Jaczewskiego 2
20-090 Lublin
SWIFT CODE: PKOPPLPW
IBAN: PL59 1240 5497 1978 0010 4070 5964
or
Data for transfer (100 PLN and 400 PLN):
Instytut Medycyny Wsi
Jaczewskiego 2
20-090 Lublin
SWIFT CODE: PKOPPLPW
IBAN: PL48 1240 5497 1111 0010 4069 9654

All fees associated with bank transfer are covered by the payer author.


ATTENTION
According to Article 106b of The Goods and Services Tax Act of 11 March 2004 (Journal of Laws 2004, No. 54, Item 535 with later amendments), from 1 January 2020, issuing an invoice for a company receipt is possible only when the taxpayer identification number of the buyer is provided on the receipt. Invoices will not be issued for receipts without the taxpayer ID number.
In connection with the above, persons who apply for the issuing of an invoice for a company receipt are kindly requested to inform the cashier about this fact before issuing a cash register receipt, and to provide the relevant taxpayer ID number.

12. Proofs
One set of page proofs (as PDF files) will be sent by email to the corresponding author or a link will be provided in the email so that authors can download the files themselves. Termedia provides authors with PDF proofs which can be annotated; for this you will need to download Adobe Reader version 10 (or higher) available free from https://get.adobe.com/uk/reader/
If you do not wish to use the PDF annotations function, you may list the corrections and return them to the Publisher in an email.
Please list your corrections quoting line number. If, for any reason, this is not possible, then mark the corrections and any other comments on a printout of your proof and return by fax, or scan the pages and email, or by post.
Please use this proof only for checking the typesetting, editing, completeness and correctness of the text, tables and figures. Significant changes to the article as accepted for publication will only be considered at this stage with permission from the Editor. The Publisher will do everything possible to get your article published quickly and accurately – please send all your corrections within 48 hours. It is important to ensure that all corrections are sent back to the Publisher in one communication: please check carefully before replying, as inclusion of any subsequent corrections cannot be guaranteed. Proofreading is solely your responsibility.

13. Requirements concerning formatting of the manuscript and illustrations
• The manuscript should be sent in the form of electronic files without final formatting (preferably 12 point font, 1.5 line spacing, paragraphs distinguished with a one line space between each paragraph, titles must not be distinguished by a different font, do not split words between lines, columns in tables divided by single tabulator, do not format by repeating spaces, do not precede punctuation marks by spaces, do not use so-called ‘hard space’.
• llustrations, prints, graphs, and photos must be submitted in separate files. Their proper position in the text should be indicated. Numerical data should be added to create the graphs.
• When in doubt, please contact the address: jpccr.edit@gmail.com, tel. +48 817184 491.